InspireMD Q2 2024 GAAP EPS $(0.22) Misses $(0.20) Estimate, Sales $1.739M Miss $1.740M Estimate
Portfolio Pulse from Benzinga Newsdesk
InspireMD reported its Q2 2024 financial results, with a GAAP EPS of $(0.22), missing the $(0.20) estimate. Sales were $1.739 million, slightly below the $1.740 million estimate.
August 06, 2024 | 10:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
InspireMD's Q2 2024 financial results showed a GAAP EPS of $(0.22), missing the $(0.20) estimate, and sales of $1.739 million, slightly below the $1.740 million estimate.
The company's earnings per share and sales both missed analyst estimates, which is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100